Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 100033819
MIM: 615509
HGNC: 33351
Ensembl: ENSG00000284010
miRBase:
Variants:
dbSNP: 100033819
ClinVar: 100033819
TCGA: ENSG00000284010
COSMIC: MIR675
RNA/Proteins
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38791169 | 2024 | Increased H19/miR-675 Expression in Adult T-Cell Leukemia Is Associated with a Unique Notch Signature Pathway. | 0 |
| 38791169 | 2024 | Increased H19/miR-675 Expression in Adult T-Cell Leukemia Is Associated with a Unique Notch Signature Pathway. | 0 |
| 37373137 | 2023 | MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer. | 1 |
| 37678441 | 2023 | N6-methyladenosine-modified microRNA-675 advances the development of gastrointestinal stromal tumors via inhibiting myosin phosphatase targeting protein 1. | 0 |
| 37373137 | 2023 | MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer. | 1 |
| 37678441 | 2023 | N6-methyladenosine-modified microRNA-675 advances the development of gastrointestinal stromal tumors via inhibiting myosin phosphatase targeting protein 1. | 0 |
| 35145234 | 2022 | CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis. | 18 |
| 35596172 | 2022 | Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells. | 6 |
| 36671388 | 2022 | The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients. | 2 |
| 35145234 | 2022 | CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis. | 18 |
| 35596172 | 2022 | Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells. | 6 |
| 36671388 | 2022 | The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients. | 2 |
| 33400243 | 2021 | Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma. | 7 |
| 33513878 | 2021 | LncRNA H19-Derived miR-675-5p Accelerates the Invasion of Extravillous Trophoblast Cells by Inhibiting GATA2 and Subsequently Activating Matrix Metalloproteinases. | 10 |
| 33649811 | 2021 | Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells. | 14 |
Citation
Dessen P
MIR675 (microRNA 675)
Atlas Genet Cytogenet Oncol Haematol. 2010-05-01
Online version: http://atlasgeneticsoncology.org/gene/51449/mir675
